Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway

Arthritis Research and Therapy

Volumn 14, Issue 4, 2012, Pages

  Wei, Fangyuan ^a,b,c   Moore, Douglas C ^a   Li, Yanlin ^a,b   Zhang, Ge ^d   Wei, Xiaochun ^e   Lee, Joseph K ^f   Wei, Lei ^a,e  

^a BROWN UNIVERSITY   (United States)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^e SHANXI MEDICAL UNIVERSITY   (China)

^f NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; COLLAGENASE 3; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROTEIN; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; HETEROCYCLIC COMPOUND; PLERIXAFOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CARTILAGE INJURY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; GUINEA PIG; HISTOPATHOLOGY; INCUBATION TIME; MALE; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RANDOMIZATION;

AGED; ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL12; FEMALE; GUINEA PIGS; HETEROCYCLIC COMPOUNDS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; RANDOM ALLOCATION; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION;

EID: 84864374820     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3930     Document Type: Article

References (49)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum 2008, 58:26-35. 10.1002/art.23176, 3266664, 18163497.
2. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005, 52:128-135. 10.1002/art.20776, 15641080.
3. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001, 44:1237-1247. 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F, 11407681.
4. Creamer P. Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how?. Ann Rheum Dis 1997, 56:634-636. 10.1136/ard.56.11.634, 1752292, 9462163.
5. Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ 2004, 328:869. 10.1136/bmj.38039.573970.7C, 387479, 15039276.
6. Pulsatelli L, Dolzani P, Piacentini A, Silvestri T, Ruggeri R, Gualtieri G, Meliconi R, Facchini A. Chemokine production by human chondrocytes. J Rheumatol 1999, 26:1992-2001.
7. Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998, 91:4523-4530.
8. Jo DY, Rafii S, Hamada T, Moore MA. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest 2000, 105:101-111. 10.1172/JCI7954, 382585, 10619866.
9. McGrath KE, Koniski AD, Maltby KM, McGann JK, Palis J. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol 1999, 213:442-456. 10.1006/dbio.1999.9405, 10479460.
10. Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 2002, 46:130-137. 10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D, 11817585.
11. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 2005, 105:3793-3801. 10.1182/blood-2004-11-4349, 15677562.
12. Jo DY, Hwang JH, Kim JM, Yun HJ, Kim S. Human bone marrow endothelial cells elaborate non-stromal-cell-derived factor-1 (SDF-1)-dependent chemoattraction and SDF-1-dependent transmigration of haematopoietic progenitors. Br J Haematol 2003, 121:649-652. 10.1046/j.1365-2141.2003.04326.x, 12752108.
13. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998, 95:9448-9453. 10.1073/pnas.95.16.9448, 21358, 9689100.
14. Wei LKK, Lee M, Wei X, Pei M, Sun X, Terek R, Chen Q. Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation. Dev Biol 2010, 341:236-245. 10.1016/j.ydbio.2010.02.033, 2862458, 20206617.
15. Kanbe K, Takemura T, Takeuchi K, Chen Q, Takagishi K, Inoue K. Synovectomy reduces stromal-cell-derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis. J Bone Joint Surg Br 2004, 86:296-300. 10.1302/0301-620X.86B2.14474, 15046450.
16. Carlson CS, Loeser RF, Purser CB, Gardin JF, Jerome CP. Osteoarthritis in cynomolgus macaques: III: Effects of age, gender, and subchondral bone thickness on the severity of disease. J Bone Miner Res 1996, 11:1209-1217.
17. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 883:173-177. 10.1016/0304-4165(86)90306-5, 3091074.
18. Wei L, Sun X, Kanbe K, Wang Z, Sun C, Terek R, Chen Q. Chondrocyte death induced by pathological concentration of chemokine stromal cell-derived factor-1. J Rheumatol 2006, 33:1818-1826.
19. Chen Y, Stamatoyannopoulos G, Song CZ. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 2003, 63:4801-4804.
20. Wei L, Sun X-J, Wang Z, Chen Q. CD95-induced osteoarthritic chondrocyte apoptosis and necrosis: dependency on p38 mitogen-activated protein kinase. Arthritis Res Ther 2006, 8:R37. 10.1186/ar1891, 1526592, 16469115.
21. Namdari S, Wei L, Moore D, Chen Q. Reduced limb length and worsened osteoarthritis in adult mice after genetic inhibition of p38 MAP kinase activity in cartilage. Arthritis Rheum 2008, 58:3520-3529. 10.1002/art.23999, 2774253, 18975318.
22. Wei L, Fleming BC, Sun X, Teeple E, Wu W, Jay GD, Elsaid KA, Luo J, Machan JT, Chen Q. Comparison of differential biomarkers of osteoarthritis with and without posttraumatic injury in the Hartley guinea pig model. J Orthop Res 2010, 28:900-906. 2875364, 20108346.
23. Meachim G. Light microscopy of Indian ink preparations of fibrillated cartilage. Ann Rheum Dis 1972, 31:457-464. 10.1136/ard.31.6.457, 1005976, 4117785.
24. van der Sluijs JA, Geesink RG, van der Linden AJ, Bulstra SK, Kuyer R, Drukker J. The reliability of the Mankin score for osteoarthritis. J Orthop Res 1992, 10:58-61. 10.1002/jor.1100100107, 1727936.
25. Borzi RM, Mazzetti I, Cattini L, Uguccioni M, Baggiolini M, Facchini A. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 2000, 43:1734-1741. 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B, 10943863.
26. Fermas S, Gonnet F, Sutton A, Charnaux N, Mulloy B, Du Y, Baleux F, Daniel R. Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis. Glycobiology 2008, 18:1054-1064. 10.1093/glycob/cwn088, 18796646.
27. Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M, Gallagher J, Werb Z, Rosen SD. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem 2006, 7:2. 10.1186/1471-2091-7-2, 1386684, 16417632.
28. Mbemba E, Benjouad A, Saffar L, Gattegno L. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells. Virology 1999, 265:354-364. 10.1006/viro.1999.0033, 10600606.
29. Wei L, Hjerpe A, Brismar BH, Svensson O. Effect of load on articular cartilage matrix and the development of guinea-pig osteoarthritis. Osteoarthr Cartilage 2001, 9:447-453.
30. Wei L, Svensson O, Hjerpe A. Correlation of morphologic and biochemical changes in the natural history of spontaneous osteoarthrosis in guinea pigs. Arthritis Rheum 1997, 40:2075-2083. 10.1002/art.1780401121, 9365098.
31. Kuhn K, D'Lima DD, Hashimoto S, Lotz M. Cell death in cartilage. Osteoarthr Cartilage 2004, 12:1-16.
32. Aigner T, Hemmel M, Neureiter D, Gebhard PM, Zeiler G, Kirchner T, McKenna L. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum 2001, 44:1304-1312. 10.1002/1529-0131(200106)44:6<1304::AID-ART222>3.0.CO;2-T, 11407689.
33. Wei L, Brismar BH, Hultenby K, Hjerpe A, Svensson O. Distribution of chondroitin 4-sulfate epitopes (2/B/6) in various zones and compartments of articular cartilage in guinea pig osteoarthrosis. Acta Orthop Scand 2003, 74:16-21. 10.1080/00016470310013590, 12635787.
34. Mazzetti I, Magagnoli G, Paoletti S, Uguccioni M, Olivotto E, Vitellozzi R, Cattini L, Facchini A, Borzi RM. A role for chemokines in the induction of chondrocyte phenotype modulation. Arthritis Rheum 2004, 50:112-122. 10.1002/art.11474, 14730607.
35. Hart CA, Brown M, Bagley S, Sharrard M, Clarke NW. Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. Br J Cancer 2005, 92:503-512. 2362089, 15668715.
36. Bendele AM, Hulman JF. Spontaneous cartilage degeneration in guinea pigs. Arthritis Rheum 1988, 31:561-565. 10.1002/art.1780310416, 3358814.
37. Matthys P, Hatse S, Vermeire K, Wuyts A, Bridger G, Henson GW, De Clercq E, Billiau A, Schols D. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J Immunol 2001, 167:4686-4692.
38. Hendrix CW, Flexner C, MacFarland RT, Giandomenico C, Fuchs EJ, Redpath E, Bridger G, Henson GW. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 2000, 44:1667-1673. 10.1128/AAC.44.6.1667-1673.2000, 89930, 10817726.
39. Hendrix CW, Collier AC, Lederman MM, Schols D, Pollard RB, Brown S, Jackson JB, Coombs RW, Glesby MJ, Flexner CW, Bridger GJ, Badel K, MacFarland RT, Henson GW, Calandra G, . Group AHS Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr 2004, 37:1253-1262. 10.1097/01.qai.0000137371.80695.ef, 15385732, Group AHS.
40. Hitchon C, Wong K, Ma G, Reed J, Lyttle D, El-Gabalawy H. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 2002, 46:2587-2597. 10.1002/art.10520, 12384916.
41. Blaine TA, Cote MA, Proto A, Mulcahey M, Lee FY, Bigliani LU. Interleukin-1beta stimulates stromal-derived factor-1alpha expression in human subacromial bursa. J Orthop Res 2011, 29:1695-1699. 10.1002/jor.21416, 21484857.
42. Kim YS, Bigliani LU, Fujisawa M, Murakami K, Chang SS, Lee HJ, Lee FY, Blaine TA. Stromal cell-derived factor 1 (SDF-1, CXCL12) is increased in subacromial bursitis and downregulated by steroid and nonsteroidal anti-inflammatory agents. J Orthop Res 2006, 24:1756-1764. 10.1002/jor.20197, 16779827.
43. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001, 44:1237-1247. 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F, 11407681.
44. Clements KM, Price JS, Chambers MG, Visco DM, Poole AR, Mason RM. Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum 2003, 48:3452-3463. 10.1002/art.11355, 14673996.
45. Blom AB, van der Kraan PM, van den Berg WB. Cytokine targeting in osteoarthritis. Curr Drug Targets 2007, 8:283-292. 10.2174/138945007779940179, 17305506.
46. Santangelo KS, Bertone AL. Effective reduction of the interleukin-1beta transcript in osteoarthritis-prone guinea pig chondrocytes via short hairpin RNA mediated RNA interference influences gene expression of mediators implicated in disease pathogenesis. Osteoarthr Cartilage 2011, 19:1449-1457.
47. Catterall JB, Stabler TV, Flannery CR, Kraus VB. Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Res Ther 2010, 12:R229. 10.1186/ar3216, 3046542, 21194441.
48. Darabos N, Hundric-Haspl Z, Haspl M, Markotic A, Darabos A, Moser C. Correlation between synovial fluid and serum IL-1beta levels after ACL surgery: preliminary report. Int Orthop 2009, 33:413-418. 10.1007/s00264-008-0649-1, 2899090, 18751702.
49. Huebner JL, Kraus VB. Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. Osteoarthr Cartilage 2006, 14:923-930.